Intercell: positive results from two Phase III studies supporting pediatric label extension of JE vaccine

Vienna – Intercell AG (VSE; “ICLL”) today announced the successful completion of a pivotal Phase III trial in 1869…

CeMM & vetmeduni: Jak of all trades? Not of leukaemia therapy!

(Vienna, 2012-01-30) About one in five or six cases of adult leukaemia in Western populations relates to so-called…

Business Treff at AME International

In January 2012 the Vienna-based company AME International GmbH opened their doors to the public interested in life…

Roche enters into a strategic alliance with Technoclone

Ziel ist die Erweiterung des Reagenzportfolios von Roche in der Gerinnungsdiagnostik

LISAvienna News

Business Treff at AME International

In January 2012 the Vienna-based company AME International GmbH opened their doors to the public interested in life…

Two Pi awarded First Prize for Innovations in User-centered Hearing Aid Fitting

The Viennese company Two Pi has captured first prize in the “Life Sciences 2011” event organized by the Technology…

International Contacts Boost Business

Networking on an international level is essential for successful companies. With this in mind many Austrian companies…

AVIR Green Hills reaches important Milestone

 

AVIR Green Hills Biotechnology AG is testing the trivalent influenza vaccine deltaFLU in a phase I/II study at the…

F-Star and Merck Serono to Collaborate in the Discovery and Development of Novel Targeted Biologics

 

Vienna, Austria, (September 7th 2011) -- F-Star GmbH today announced that a research, license and commercialisation…

Apeiron acquires rights for Phase III immunotherapy against high-risk neuroblastoma from CCRI and SIOPEN

APEIRON Biologics AG (Apeiron) today announced the signing of agreements with the Children’s Cancer Research Institute,…

Best of Biotech 2010: The Winners

In October 2010, the international life science business plan competition “Best of Biotech” (BOB) – funded by the…

Best of Biotech 2010: The Winners

In October 2010, the international life science business plan competition “Best of Biotech” (BOB) – funded by the…